Loopback Analytics Announces Strategic Growth Investment by PSG
Investment aims to accelerate growth trajectory and expand offerings to health system and life sciences organizations, including payor access services and therapy-specific outcomes initiatives
DALLAS - Loopback Analytics (“Loopback”), a leading provider of analytics and data-enabled services for health systems and life sciences organizations, today announced a strategic growth investment by PSG, a leading growth equity firm partnering with software and technology-enabled services companies to help accelerate their growth. Loopback founder Neil Smiley will continue to serve as CEO alongside the current leadership team.
Founded in 2009, Loopback connects health systems and life sciences organizations through analytics and data-enabled services to enhance health systems’ specialty pharmacy efforts, maximize opportunities for improved patient-centered care, and capture and share real world data to develop therapy-specific best practices. By standardizing and normalizing data from clinical, prescribing and dispensing systems used by major health systems, Loopback’s platform aims to enable advanced analytics and medical insights. The company serves a large and growing addressable market across all therapeutic areas.
Loopback will aim to use the investment proceeds to further build out its data and analytics capabilities, including its recently launched payor access services offering and therapy-specific outcomes initiatives, which help unite leading health systems focused on developing consensus around selection and calculation of relevant clinical endpoints on a therapy-specific basis. To support that expansion, the company recently appointed Jerry Buller as Vice President of Payor Access Services.
“Our growth and momentum these past few years speak to the value of our solutions across all specialty pharmacy and life sciences stakeholders,” said Mr. Smiley. “We are grateful for our employees, customers, and partners who make it possible for us to successfully support our target market. Not only does PSG recognize what we have accomplished, but they also share our go-forward vision of further enhancing Loopback’s value proposition to improve patient outcomes and help reduce their total cost of care.”
“We are thrilled to be partnering with Neil and the Loopback team to continue supporting their growth trajectory within the health system and life sciences markets,” said Reid McCann, Principal at PSG. “We believe Neil and his team have a differentiated set of solutions and capabilities that will be complemented by the expansion into payor access services and the further development of therapy-specific outcomes.”
William Blair served as financial advisor to Loopback Analytics. Weil, Gotshal & Manges LLP served as legal advisor to PSG.
About Loopback Analytics
Founded in 2009, Loopback Analytics is a leading provider of data analytics and insights that simplify understanding, access and innovation for patients requiring specialty care. Its mission is to connect Health Systems and Life Sciences through analytics and data-enabled services. Loopback serves over 40 health system clients, 350+ hospitals and thousands of clinics nationwide. To learn more about Loopback Analytics, visit www.loopbackanalytics.com.
About PSG Equity
PSG Equity (“PSG”) is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities and build strong teams. Having backed more than 120 companies and facilitated over 450 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Paris, Madrid and Tel Aviv. To learn more about PSG, visit www.psgequity.com.